Indications for use:
NBS 6 (FDA K170902, K182700): Nexstim NBS 6 is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. The Nexstim NBS 6 is intended to be used by trained clinical professionals.